Triple

T1633922
Position Surface form Disambiguated ID Type / Status
Subject Calico LLC E35320 entity
Predicate enteredStrategicR&DAllianceWith P23002 FINISHED
Object AbbVie E184183 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: AbbVie | Statement: [Calico LLC, enteredStrategicR&DAllianceWith, AbbVie]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: AbbVie
Context triple: [Calico LLC, enteredStrategicR&DAllianceWith, AbbVie]
  • A. AbbVie chosen
    AbbVie is a global biopharmaceutical company known for developing and marketing innovative therapies in areas such as immunology, oncology, and neuroscience.
  • B. Pfizer
    Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
  • C. Abbott Laboratories
    Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, branded generic medicines, and nutritional products.
  • D. Novartis
    Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
  • E. AstraZeneca
    AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07 
Target predicate: enteredStrategicR&DAllianceWith
Context triple: [Calico LLC, enteredStrategicR&DAllianceWith, AbbVie]
  • A. hasJointVenture
    Indicates that two or more entities are engaged together in a formally established joint business venture or collaborative commercial undertaking.
  • B. coalitionPartnerWith
    Indicates that two entities are formally aligned in a cooperative coalition, sharing goals or actions as partners within that coalition.
  • C. allianceCreated chosen
    Indicates that a formal cooperative relationship or partnership has been established between two or more parties.
  • D. allianceType
    Indicates the specific kind or category of alliance relationship that exists between entities.
  • E. formedAsPartnershipBetween
    Indicates that something was created or established through a formal partnership between two or more entities.
  • F. None of above.

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a886036bc081909ff5de16dbe5e8ea completed March 4, 2026, 7:20 p.m.
NER Named-entity recognition batch_69a96083e7308190abbf025fe8e43abb completed March 5, 2026, 10:52 a.m.
NED1 Entity disambiguation (via context triple) batch_69ad6815c4588190bccfbece8f22c1a1 completed March 8, 2026, 12:14 p.m.
PD Predicate disambiguation batch_69a907cac610819083cafd4396b6d66c completed March 5, 2026, 4:34 a.m.
Created at: March 4, 2026, 7:28 p.m.